NSE - Delayed Quote INR
Biocon Limited (BIOCON.NS)
326.75
-8.95
(-2.67%)
At close: 3:30:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
29,539,000
18,525,000
11,766,000
11,597,000
Investing Cash Flow
--
-10,045,000
-142,818,000
-16,991,000
-36,247,000
Financing Cash Flow
--
-23,327,000
130,487,000
2,421,000
25,640,000
End Cash Position
--
9,195,000
12,948,000
6,537,000
8,970,000
Capital Expenditure
--
-19,316,000
-17,263,000
-19,248,000
-17,463,000
Issuance of Capital Stock
--
307,000
12,663,000
428,000
8,070,000
Issuance of Debt
--
13,718,000
109,399,000
10,701,000
26,569,000
Repayment of Debt
--
-27,678,000
-281,000
-10,949,000
-7,336,000
Repurchase of Capital Stock
--
--
-647,000
-3,000
-93,000
Free Cash Flow
--
10,223,000
1,262,000
-7,482,000
-5,866,000
3/31/2021 - 4/7/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DCAL.NS Dishman Carbogen Amcis Limited
215.43
+3.12%
UCB.VI UCB SA
145.60
-0.31%
LYKALABS.NS Lyka Labs Limited
116.35
-0.26%
CONCORDBIO.NS Concord Biotech Limited
1,650.70
+0.13%
BLUEJET.NS Blue Jet Healthcare Limited
764.45
+2.58%
PANACEABIO.NS Panacea Biotec Limited
538.35
+4.95%
LEGN Legend Biotech Corporation
34.18
-0.36%
GMAB Genmab A/S
20.46
+1.64%
RPRX Royalty Pharma plc
32.03
+1.07%
ARGX argenx SE
603.25
+1.45%